secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genprex, Inc. (GNPX)
CIK:        0001595248
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001437749-25-031678
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genprex announces $2.7M registered direct offering plus warrants for up to $5.4M; Nasdaq compliance risk remains
--------------------------------------------------------------------------------

- Issued 243,622 shares at $11.21/sh for ~$2.7M gross proceeds; net ~$2.3M after fees.
- Concurrent private placement of warrants to purchase up to 487,244 shares at $11.00/sh, exercisable for 24 months.
- Company still at risk of Nasdaq delisting; reverse stock split (1:50) implemented Oct 21, 2025; exception expires Oct 31, 2025.
- Proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acting as placement agent; fees 7% cash plus warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595248/000143774925031678/0001437749-25-031678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595248/000143774925031678/gnpx20251021_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer